NCT06675981

Brief Summary

This study aims to conduct a randomized controlled trial to investigate the difference in clinical efficacy and blinding effect between real acupuncture and various sham acupuncture techniques.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
150

participants targeted

Target at P75+ for not_applicable knee-osteoarthritis

Timeline
Completed

Started Nov 2024

Shorter than P25 for not_applicable knee-osteoarthritis

Geographic Reach
1 country

2 active sites

Status
not yet recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

November 4, 2024

Completed
2 days until next milestone

First Posted

Study publicly available on registry

November 6, 2024

Completed
4 days until next milestone

Study Start

First participant enrolled

November 10, 2024

Completed
5 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

April 1, 2025

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

April 1, 2025

Completed
Last Updated

November 19, 2024

Status Verified

November 1, 2024

Enrollment Period

5 months

First QC Date

November 4, 2024

Last Update Submit

November 18, 2024

Conditions

Keywords

Sham acupunctureRandomized controlled trialBlinding effectPlacebo acupuncture

Outcome Measures

Primary Outcomes (1)

  • Western Ontario and McMaster Universities Osteoarthritis index (WOMAC)

    The WOMAC, a disease-specific scale with high reliability and validity, has been translated into different languages and used widely in clinical trials for KOA. The Chinese version of WOMAC contains 24 items that measure pain (5 items, scored 0-50), stiffness (2 items, scored 0-20) and physical function (17 items, scored 0-170), with a total score ranging from 0 to 240

    2 week

Secondary Outcomes (3)

  • Visual analogue scale (VAS)

    2 week

  • Blind Assessment Scale

    2 week

  • Massachusetts General Hospital Acupuncture Sensation Scale (MASS)

    2 week

Study Arms (5)

Real Acupuncture

EXPERIMENTAL

Acupuncture at nine acupoints. Patients received 6 sessions of acupuncture (three sessions per week or every other day) for two consecutive weeks

Other: Real Acupuncture

Non-acupuncture at real-acupoint

SHAM COMPARATOR

The acupuncture simulation device will be used to perform acupuncture at the same acupoints as those of the real acupuncture group.

Other: Non-acupuncture at real-acupoint

Shallow acupuncture at real-acupoint

SHAM COMPARATOR

At the same acupoint in the acupuncture group, the subcutaneous puncture is only 1-2 mm, no manipulation will be applied

Other: Shallow acupuncture at real-acupoint

Shallow acupuncture at non-meridian and non-acupoint

SHAM COMPARATOR

At non-meridian and non-acupoint, the subcutaneous puncture is only 1-2 mm, no manipulation will be applied

Other: Shallow acupuncture at non-meridian and non-acupoint

Waiting-list group

NO INTERVENTION

No acupuncture treatment will be given during the study period.

Interventions

Patients received 6 sessions of acupuncture (three sessions per week or every other day) for two consecutive weeks

Real Acupuncture

The acupuncture simulation device will be used to perform acupuncture at the same acupoints as those of the real acupuncture group.

Non-acupuncture at real-acupoint

At the same acupoint in the acupuncture group, the subcutaneous puncture is only 1-2 mm, no manipulation will be applied

Shallow acupuncture at real-acupoint

At non-meridian and non-acupoint, the subcutaneous puncture is only 1-2 mm, no manipulation will be applied

Shallow acupuncture at non-meridian and non-acupoint

Eligibility Criteria

Age40 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Clinical diagnosis of knee osteoarthritis.
  • Age over 40 years old.

You may not qualify if:

  • Tuberculosis, tumors, rheumatism of the knee joint, and rheumatoid arthritis.
  • Sprain or trauma in the lower limb.
  • Mental disorders.
  • Severe cardiovascular disease, liver or kidney impairment, immunodeficiency, diabetes mellitus, blood disorder or skin disease.
  • Pregnancy or lactation.
  • Use of physiotherapy for osteoarthritis knee pain in the past month; use of intra-articular injection of glucocorticoid or viscosupplementation in the past 6 months; received knee-replacement surgery; and positive floating patella test.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (2)

Affiliated Hospital of Jiangxi University of Traditional Chinese Medicine

Nanchang, Jiangxi, 330000, China

Location

Affiliated Hospital of Chengdu University of Traditional Chinese Medicine

Chengdu, Sichuan, 610041, China

Location

MeSH Terms

Conditions

Osteoarthritis, Knee

Condition Hierarchy (Ancestors)

OsteoarthritisArthritisJoint DiseasesMusculoskeletal DiseasesRheumatic Diseases

Study Officials

  • Xin Sun, Doctor

    West China Hospital

    STUDY CHAIR

Central Study Contacts

Xin Sun, Doctor

CONTACT

Jiali Liu, Doctor

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
PARTICIPANT
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
professor

Study Record Dates

First Submitted

November 4, 2024

First Posted

November 6, 2024

Study Start

November 10, 2024

Primary Completion

April 1, 2025

Study Completion

April 1, 2025

Last Updated

November 19, 2024

Record last verified: 2024-11

Data Sharing

IPD Sharing
Will not share

Data can be shared with other researchers with the agreement of the Coordinating Committee and the Ethics Committee.

Locations